Study guide
Antimicrobial Susceptibility, QC, and Postanalytic Reporting
ASCP MLT Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 ASCP MLT Exam Overview and Laboratory Operations
Current Exam Facts and CAT Scoring Eligibility Routes and MLT Study Strategy Laboratory Safety, Quality, and Compliance Lab Math, Instrumentation Troubleshooting, and Result Verification
2 Chemistry, Urinalysis, and Body Fluid Interpretation
Chemistry Calculations, Acid-Base, and Electrolytes Renal, Liver, Endocrine, Enzyme, TDM, and Toxicology Patterns Chemistry QC, Interferences, Specimen Handling, and Result Correlation Urinalysis Microscopy and Body Fluid Decision Patterns
3 Hematology and Hemostasis
CBC, RBC Indices, Reticulocytes, and Anemia Patterns Leukocyte Morphology, Differentials, and Disease Clues Platelet Findings, Coagulation Pathways, PT/aPTT, and Hemostasis Testing Hematology Quality Flags, Specimen Issues, and Smear Review Decisions
4 Blood Banking and Transfusion Practice
ABO/Rh Typing: Forward, Reverse, and Discrepancies Antibody Screen, Identification, DAT, Elution, and Enhancement Methods Compatibility Testing, Crossmatch, Components, and Storage Transfusion Reactions, HDFN, Donor/Product Decisions, and Safety Workflow
5 Microbiology Workups and Susceptibility Reasoning
Specimen Quality, Safety, and Culture Setup Gram Stain, Media, and Biochemical Identification Mycology, Mycobacteriology, Virology, and Parasitology Essentials Antimicrobial Susceptibility, QC, and Postanalytic Reporting
6 Immunology, Integrated Cases, and Final Review
Immunology Principles, Autoimmune Testing, Infectious Serology, and Molecular/Serologic Methods Transplant, Complement, Immunoglobulins, and Result Interpretation Integrated Case Reasoning Across Departments Final Seven-Day Review, CAT Pacing, and Remediation
Antimicrobial Susceptibility, QC, and Postanalytic Reporting
Key Takeaways Explain This Topic AI
Routine AST starts with a clinically significant, usually pure isolate and a standardized inoculum, not mixed flora or obvious contaminants.
Disk diffusion uses Mueller-Hinton agar and a 0.5 McFarland inoculum for many routine bacteria; zones or MICs must be interpreted with current laboratory-approved breakpoints.
Out-of-range AST quality control is a stop-and-troubleshoot event; affected patient susceptibility results should not be reported until QC problems are resolved according to policy.
Resistance mechanisms such as beta-lactamase, ESBL, carbapenemase, mecA-mediated MRSA, vanA or vanB VRE, and inducible clindamycin resistance are tested phenotypically or genetically depending on the workflow.
Postanalytic microbiology includes critical result communication, documentation, corrected reports, infection prevention notification, public health reporting, and suppression of misleading antibiotic results.
Last updated: May 2026
Susceptibility Testing Is a Controlled Measurement
Antimicrobial susceptibility testing is not just placing antibiotic disks on a plate. It is a controlled test that begins with the right isolate, a standardized inoculum, approved media, correct incubation, current interpretive criteria, and acceptable quality control. On the ASCP MLT exam, AST questions often test whether you know when not to report.
Routine AST Setup Checklist
Step Correct bench reasoning Common error tested
Isolate selection Use a clinically significant, pure isolate when routine AST is indicated Testing mixed flora or a likely contaminant without workup context
Inoculum Adjust to a 0.5 McFarland standard for many routine disk diffusion methods Heavy or light inoculum causing false resistance or susceptibility
Medium Mueller-Hinton agar for routine Kirby-Bauer disk diffusion, with special formulations when required Using blood agar, Sabouraud, or random media for routine disk diffusion
Disk or panel Use in-date materials stored correctly Expired disks or panels can produce invalid results
Incubation Follow organism-specific time, temperature, and atmosphere Incubating in the wrong atmosphere or reading too early or late
Interpretation Use current CLSI, FDA, or laboratory-adopted breakpoints according to policy Applying outdated or manually invented breakpoints
- QC Verify control strains are within expected range Reporting patient AST when affected QC is out of range
- What S, I, and R Mean at the Bench
Susceptible, intermediate, susceptible-dose dependent, and resistant categories are interpretive categories, not raw measurements. A zone diameter or MIC becomes clinically useful only after it is interpreted with an approved breakpoint for that organism and drug combination. The same MIC may not mean the same thing for every organism.
A bench answer should also respect intrinsic resistance . If an organism is intrinsically resistant to an antimicrobial, the lab should not report that agent as susceptible just because an instrument generated a number. Many laboratories suppress misleading agents, use cascade reporting, and require review of unusual phenotypes.
Resistance Mechanism Table
Resistance clue Common test or result pattern Reporting idea
MRSA mecA or PBP2a detection, or cefoxitin screen depending on SOP Report as methicillin-resistant Staphylococcus aureus and follow beta-lactam reporting rules
VRE vanA or vanB detection, or phenotypic vancomycin resistance Important for infection prevention and isolation decisions
ESBL Phenotypic or molecular detection in Enterobacterales depending on workflow May alter cephalosporin reporting under current policy
Carbapenemase Phenotypic carbapenemase test or genes such as blaKPC Often requires confirmation, infection prevention, and sometimes public health action
Beta-lactamase Rapid beta-lactamase test in selected organisms Can explain penicillin or ampicillin resistance patterns
Inducible clindamycin resistance D-test with erythromycin and clindamycin disks; D-shaped blunting near erythromycin Report clindamycin resistant when inducible resistance is detected
QC Failure Decision Tree
Is the control strain result within the expected range?
If yes, continue interpretation if all other acceptance criteria are met.
If no, stop affected reporting and determine the scope of the problem.
Check inoculum density, purity, media depth, pH, cation content, disk potency, panel storage, incubation conditions, and reader or instrument performance.
Repeat QC or testing according to SOP.
Release patient AST only when the QC issue is resolved and policy permits reporting.
Postanalytic Reporting
Postanalytic microbiology is a patient-safety phase. A positive blood culture Gram stain is commonly an urgent preliminary report because it can change therapy before final identification and susceptibility are complete. The report should include the preliminary Gram result as allowed by policy, the notification time, the person notified, and documentation.
Result review asks whether the report makes clinical and microbiologic sense. Do not issue susceptibility results on mixed normal flora as though there is a single pathogen. Do not hide a critical Gram stain while waiting for final ID. Do not leave an incorrect organism or susceptibility report uncorrected; corrected reports must be issued and documented according to policy.
Some results require infection prevention or public health notification. Examples include multidrug-resistant organisms, possible select agents, clusters, or reportable pathogens. The MLT role is to recognize the trigger, follow SOP, document communication, and avoid unsupported interpretation beyond the laboratory result.
Final AST Reporting Checklist
Before releasing susceptibility results, ask these questions: Is the isolate clinically significant? Is the culture pure enough for valid testing? Did QC pass? Are current breakpoints applied? Are intrinsic resistance and suppression rules addressed? Are unusual phenotypes reviewed? Are critical or preliminary results communicated and documented? If any answer is no, the safest exam choice is usually to troubleshoot, hold, confirm, or escalate rather than report blindly.